期刊文献+

肝功能衰竭患儿如何进行营养支持 被引量:2

How to nutritional support for pediatric liver failure
原文传递
导出
摘要 肝功能衰竭患儿营养障碍原因包括营养摄入、吸收不良和代谢改变等,常导致预后不良。临床上宜根据肝功能衰竭的原因与病情选择合适的营养支持途径,包括胃肠营养、胃肠外营养或混合营养。严重急性肝功能衰竭或合并肝昏迷的患儿尽可能在5—7d内开始胃肠营养,进行个体化的综合营养状况及能量代谢评估,按照代谢需求与代谢能力提供适当的能量和营养素,并及时地调整营养支持措施。 Malnutrition occurs as a result of inadequate nutrient intake, malabsorption and altered metabolism in pediatric liver failure. Malnutrition may be associated with a poor outcome. The current evidence indicates that the provision of adjunctive nutritional support ( parenteral nutrition or enteral nutrition or nutritional supplements) to patients with a variety of liver diseases. It may be reasonable to start enteral nutrition in 5 to 7 days in acute liver failure or hepatic coma. According to individualized appropriate nutritional evaluation, the metabolic demand, to provide appropriate nutritional support in pediatric liver failure.
作者 张育才 熊熙 ZhangYucai Xiong Xi.(Department of Critical Care Medicine, Shanghai Children ~ Hospital, Shanghai Jiaotong University, Shanghai 200040, Chin)
出处 《中国小儿急救医学》 CAS 2017年第1期13-16,共4页 Chinese Pediatric Emergency Medicine
基金 上海市科委西医科技引导类项目(16411970300)
关键词 肝功能衰竭 营养不良 营养支持 儿童 Liver failure Malnutrition Nutritional support Children
  • 相关文献

参考文献2

二级参考文献67

  • 1Jiang, Ming,Liu, Fei,Xiong, Wu-Jun,Zhong, Lan,Xu, Wen,Xu, Fei,Liu, Yan-Bing.Combined MELD and blood lipid level in evaluating the prognosis of decompensated cirrhosis[J].World Journal of Gastroenterology,2010,16(11):1397-1401. 被引量:14
  • 2舒晓亮,康凯,钟静霞,姬舒荣,张勇胜,胡怀东,张大志.高支链氨基酸营养支持对肝脏手术患者肝功能保护作用的Meta分析[J].中华肝脏病杂志,2014,22(1). 被引量:9
  • 3LutzW.Weber,MeinradBoll,AndreasStampfl.Maintaining cholesterol homeostasis: Sterol regulatory element-binding proteins[J].World Journal of Gastroenterology,2004,10(21):3081-3087. 被引量:17
  • 4Harry R. Davis,Scott W. Altmann.Niemann–Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter[J]. BBA - Molecular and Cell Biology of Lipids . 2009 (7)
  • 5Joseph L. Goldstein,Michael S. Brown.The LDL Receptor[J]. Arteriosclerosis, Thrombosis, and Vascular Biology . 2009 (4)
  • 6Alexey Sorokin,Jennifer L. Brown,Paul D. Thompson.??Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review(J)Atherosclerosis . 2006 (2)
  • 7Longo M,Crosignani A,Battezzati P M,Squarcia Giussani C,Invernizzi P,Zuin M,Podda M.Hyperlipidaemic state and cardiovascular risk in primary biliary cirrhosis. Gut . 2002
  • 8Horton JD,Goldstein JL,Brown MS.SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. The Journal of Clinical Investigation . 2002
  • 9Peter Toth,Thomas Dayspring,Phan.??Ezetimibe therapy: mechanism of action and clinical update(J)Vascular Health and Risk Management . 2012 (defa)
  • 10T.A. Miettinen,H. Gylling,M.J. Nissinen.??The role of serum non-cholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption(J)Nutrition, Metabolism and Cardiovascular Diseases . 2011 (10)

共引文献18

同被引文献30

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部